Nasdaq-listed Nucana has some promising cancer therapies in drug trials and an experienced leader.
Category: NYSE:XLV
Two Mistakes Investors Make When Investing In Biotechnology Companies
Biotechnology stocks were some of the strongest performing stocks from 2009-2015. Then, the biotech bubble burst and just about every major biotech stock plunged into a private bear market.
